Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More



Comments (0) | Trackbacks (0) | Permalink

Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: » More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
cigarettes placebo post-traumatic stress disorder fentanyl Harold Urschel urine drug screen substance dependence health insurance withdrawal data mining alcohol addiction treatment drug use heroin buprenorphine behavioral health care randomized contract methamphetamine dependence nicotine prometa behavioral health opiod abuse Catasys drug treatment Opioid Medications smoking hospital reduction in craving opioid antagonist ADHD opioid-drug interactions naloxone pain medication flumazenil morphine facebook health insurance communication opioid vicodin meth CIWA codeine placebo-controlled opioid overdose behavioral healthcare PTSD stimulants substance use disorder relapse mental illness craving alcohol dependence drug addicts stress drug addiction drinking emergency room methadone drug abuse Co Occurring Disorders sugar pain killers behavioral healthcare services trauma addict anxiety relapse prevention cocaine opioid abuse gabapentin depression high-utilizing treatment hospitalizations over-the-counter substances muscle relaxant alcoholism depression screening marijuana narcotic sobriety OxyContin bipolar disorder prescriptions OnTrak medical costs behavioral health care services chronic pain social network substance dependence craving score binge drinking dependence issues SD members health reform identification methamphetamine Health Care Utilization opiod-based Journal of Psychopharmacology predictive modeling sober Research Across America addiction vivitrol painkillers oxycodone alcohol drinking primary care SD health insurance suboxone double-blind physician- patient relations diabetes mental health recovery ER recovery network overdose medical and behavioral costs care coaching alcohol treatment substance dependence costs cocaine treatment opiates reduction in use pain pills psychosocial Opioid Treatment percocet reducing craving health plan stratified hydrocodone medical Raymond Anton UnitedHealthcare ADD
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025